Skip to content
Disclosery

Alerce Investment Management, L.P.

Follow

13F filer, CIK 1844002, Chicago, IL

Alerce Investment Management, L.P. reported $58,509,505 across 6 holdings for the quarter ended 2023-09-30, in a 13F-HR filed 2023-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-23-000616

Period
2023-09-30
Reported value
$58.5M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2023

Share positions as resolved from 13F-HR 0000895345-23-000616, largest first. % of portfolio is the value over $58,509,505, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 16,205,119 shares; 2023Q2: 16,205,119 shares; 2023Q3: 16,205,119 shares 16,205,119$18.5M31.57%0Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 7,056,024 shares; 2023Q2: 7,056,024 shares; 2023Q3: 7,056,024 shares 7,056,024$16.7M28.46%0Timeline
AMERICAN WELL CORPAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 10,475,717 shares; 2023Q2: 10,475,717 shares; 2023Q3: 10,475,717 shares 10,475,717$12.3M20.95%0
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 1,630,830 shares; 2023Q2: 1,630,830 shares; 2023Q3: 1,630,830 shares 1,630,830$7.89M13.49%0Timeline
ASSEMBLY BIOSCIENCES INCASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 2,227,500 shares; 2023Q2: 2,227,500 shares; 2023Q3: 2,227,500 shares 2,227,500$1.97M3.37%0
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: 830,466 shares; 2023Q2: 830,466 shares; 2023Q3: 830,466 shares 830,466$1.26M2.16%0Timeline

How Q3 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-23-000616 base2023-11-13acceptance time not in the bulk data set